✦ LIBER ✦

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Scribed by Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocereto; Jennifer Vinters

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of gemcitabine and topot

✍ M. Dwight Chen; Gini F. Fleming; Suann Mitchell; Ira Horowitz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A phase I trial of dose-dense (biweekly)

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A phase I study with an expanded cohort

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Paclitaxel poliglumex and carboplatin as

✍ Mark A. Morgan; Kathleen M. Darcy; Peter G. Rose; Koen DeGeest; Michael A. Bookm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 164 KB

A phase II trial of paclitaxel poliglume

✍ Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Sec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 305 KB